Clusterin: a key player in cancer chemoresistance and its inhibition
about
sameAs
Apolipoprotein J: A New Predictor and Therapeutic Target in Cardiovascular Disease?Biomarkers for Primary Sjögren's SyndromeDynamic self-guiding analysis of Alzheimer's disease.Potential predictive plasma biomarkers for cervical cancer by 2D-DIGE proteomics and Ingenuity Pathway Analysis.Identification of novel genes that regulate androgen receptor signaling and growth of androgen-deprived prostate cancer cells.Pten Regulates Epithelial Cytodifferentiation during Prostate Development.Alterations of the Plasma Peptidome Profiling in Colorectal Cancer Progression.Making many from few: IL-12p40 as a model for the combinatorial assembly of heterodimeric cytokines.Prognostic Role of Secretory Clusterin in Multiple Human Malignant Neoplasms: A Meta-Analysis of 26 Immunohistochemistry StudiesAggressive rat prostate tumors reprogram the benign parts of the prostate and regional lymph nodes prior to metastasis.Increased extracellular clusterin in the prefrontal cortex in schizophrenia.eIF3f reduces tumor growth by directly interrupting clusterin with anti-apoptotic property in cancer cells.Biomarkers associated with bronchopulmonary dysplasia/mortality in premature infants.Systemic sclerosis biomarkers discovered using mass-spectrometry-based proteomics: a systematic review.Altered gene expression in conjunctival squamous cell carcinoma.Sequences and combinations of multifaceted therapy in advanced prostate cancer.High fidelity between saliva proteomics and the biologic state of salivary glands defines biomarker signatures for primary Sjögren's syndrome.A Systematic Review of the Diagnostic and Prognostic Value of Urinary Protein Biomarkers in Urothelial Bladder CancerProtection of host cells by complement regulators.Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis.Changes in plasma biomarkers following treatment with cabozantinib in metastatic castration-resistant prostate cancer: a post hoc analysis of an extension cohort of a phase II trial.Protective effect of clusterin on rod photoreceptor in rat model of retinitis pigmentosaOncogenic secretory clusterin in hepatocellular carcinoma: Expression at early staging and emerging molecular target.Thirty Minutes of Hypobaric Hypoxia Provokes Alterations of Immune Response, Haemostasis, and Metabolism Proteins in Human SerumClusterin modulates transdifferentiation of non-small-cell lung cancer.Liposomal co-delivery-based quantitative evaluation of chemosensitivity enhancement in breast cancer stem cells by knockdown of GRP78/CLU.Serum Proteome in a Sporadic Amyotrophic Lateral Sclerosis Geographical Cluster.Silencing clusterin gene transcription on effects of multidrug resistance reversing of human hepatoma HepG2/ADM cells.Understanding mechanisms and seeking cures for Alzheimer's disease: why we must be "extraordinarily diverse".Intraventricular apolipoprotein ApoJ infusion acts protectively in Traumatic Brain Injury.O-linked N-acetylglucosamine transferase enhances secretory clusterin expression via liver X receptors and sterol response element binding protein regulation in cervical cancer.Clusterin in Neuroendocrine Epithelial Neoplasms: Absence of Expression in a Well-differentiated Tumor Suggests a Jejunoileal Origin.Progranulin and granulin-like protein as novel VEGF-independent angiogenic factors derived from human mesothelioma cells.Knockdown of clusterin alters mitochondrial dynamics, facilitates necrosis in camptothecin-induced cancer stem cells.Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers
P2860
Q26781196-E7BFEC25-C03E-41B2-9ED0-C4BD63B77F44Q26781381-E1FD5F64-3D41-4895-8413-CFD80B89D8B7Q28080897-94806787-1817-4649-99B7-9283E3585231Q35452689-6101916F-0650-4069-B46D-A737449F5951Q35650240-630A6F23-7F47-4463-8799-1E9DC0075111Q35664021-BC720E91-5C44-44BD-9735-7FD334DFB92BQ35778619-32FEB81A-8922-43E2-8BED-9CD3C2204BD2Q36068746-A9F4DB60-F8D5-4750-B82B-517423E54ADCQ36105571-3BC0AD05-7F5D-4090-96D7-DEF0482C7E7CQ36363019-BCF2C6C3-83BE-46E9-92E4-24A92AB91376Q36378305-80160948-AA40-41E7-8C9B-FF65228560A9Q37109809-0E0F2972-25FC-4FEE-8FD4-7537FBDDCFDEQ37730750-EC260827-8860-4913-90BF-AAD67CBB953DQ38211968-C67E44AF-0679-4000-83DD-738062DCA809Q38293577-58652B3C-37FA-447F-84E6-44D520E2382DQ38391800-ED928E2E-1899-4E16-BF12-513FA490AC1EQ38468546-7A67B7BC-F652-422F-8F30-0A77189DE78FQ38921522-E5D24C39-524F-4E5F-A2E9-BA1ED1DA7155Q38991019-3BFB906F-4048-4145-B50D-0350801556C6Q39172440-E6E2B3F4-1333-4B8D-A157-FDECF842D521Q40112666-425472CE-9F5D-4D47-8DE8-B64EBB87EC63Q41214333-9BC72CCC-B511-4209-A9AB-2EC2C1C734B1Q41592701-667F58C5-213A-4785-B654-47C7A37E97F6Q41661095-AA3525B3-1654-4F2B-9548-E6EBFCDE6D11Q42200953-33ED8689-9E5A-4BE1-B5DD-A903C0CC7376Q47230976-75EBD282-D930-451C-9492-18027D808CE5Q47965356-2DB3EF7F-4C6B-4968-B365-0D6D5622F600Q48132000-93C473DA-1C88-47A8-B016-0C9AE8930D92Q48762558-581E7326-B999-4CA7-BB22-116FE9980688Q49147262-D77D8C57-4046-459B-AEF9-4E236CB32F66Q49642834-D3997D24-2814-4F9D-B018-C1205B6016D2Q50115379-64CC82B2-9C1B-457A-A0B0-018EE2B61B61Q51501402-79863F66-E710-4830-987A-FEF99460A9A1Q53754732-75D42C11-8FA3-45A4-A3FF-526AB903E10FQ57947040-B2C66567-0F44-47C4-BF3C-93C15B489716
P2860
Clusterin: a key player in cancer chemoresistance and its inhibition
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Clusterin: a key player in cancer chemoresistance and its inhibition
@ast
Clusterin: a key player in cancer chemoresistance and its inhibition
@en
Clusterin: a key player in cancer chemoresistance and its inhibition
@nl
type
label
Clusterin: a key player in cancer chemoresistance and its inhibition
@ast
Clusterin: a key player in cancer chemoresistance and its inhibition
@en
Clusterin: a key player in cancer chemoresistance and its inhibition
@nl
prefLabel
Clusterin: a key player in cancer chemoresistance and its inhibition
@ast
Clusterin: a key player in cancer chemoresistance and its inhibition
@en
Clusterin: a key player in cancer chemoresistance and its inhibition
@nl
P2860
P3181
P356
P1476
Clusterin: a key player in cancer chemoresistance and its inhibition
@en
P2093
Tomas Koltai
P2860
P304
P3181
P356
10.2147/OTT.S58622
P407
P577
2014-01-01T00:00:00Z